Cardiogenic shock: Therapy and prevention

Clinical Cardiology

Volumn 21, Issue 2, 1998, Pages 72-80

  Barry, William L ^a   Sarembock, Ian J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Cardiogenic shock; Intra aortic balloon pump; Pathophysiology; Prevention; Revascularization; Thrombolysis; Treatment

Indexed keywords

ANISTREPLASE; FIBRINOLYTIC AGENT; INOTROPIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; AORTA BALLOON; CARDIOGENIC SHOCK; COUNTERPULSATION; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; PATIENT SELECTION; REVIEW;

EID: 0031940575     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960210203     Document Type: Review

References (48)

1. Goldberg RJ, Gore JM, Alpert JS. Osganian V, De Groot J, Bade J, hen Z, Frid D, Dalen JE: Cardiogenic shock after acute myocardial infarction: Incidence and mortality from a community-wide perspective, 1975-1988. N Engl J Med 1991;325:1117-1122
2. Holmes ER, Bates ER, Kleiman NS, Sadowski Z, Morgan JHS, Morris DC, Califf RM, Berger PB, Topol EJ: Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experi- ence. J Am Coll Cardiol 1995;26:668-674
3. Califf RM, Bengston JR: Cardiogenic shock. N Engl J Med 1994; 330:1724-1730
4. Alonso DR, Scheidt S, Post M, Killip T: Pathophysiology of cardiogenic shock: Quantification of myocardial necrosis, clinical, pathologic, and electrocardiographic correlations. Circulation 1973;48:588-596
5. Saffitz JE, Frederickson RC, Roberts WC: Relation of size of transmural acute rnyocardial infarct to mode of death and frequency of coronary arterial thrombus. Am J Cardiol 1986;57:1249-1254
6. Gutovitz AL, Sobel BE, Roberts R: Progressive nature of rnyocardial injury in selected patients with cardiogenic shock. Am J Cardiol 1978;41:469-475
7. Zehender M, Kasper W, Kauder E, Schonthaler M, Geibel A, Olschewski M, Just H: Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993;328:981-988
8. Gewirtz H, Gold HK, Fallon JT, Pasternak RC, Leinbach RC: Role of right ventricular infarction in cardiogenic shock associated with inferior myocardial infarction. Br Heart J 1979;42:719-725
9. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffee AS, Cox JL: Importance of left ventricular function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia. J Am Coll Cardiol 1990;19:704-711
10. Kingh JW, Ryan TJ: Right ventricular infarction. J Engl J Med 1994;330:1211-1217
11. GISSI: Effectiveness of intravenous thrombolytic treatment in acute rnyocardial infarction. Lancet 1986;1:397-402
12. International Study Group: In hospital mortality and clinical course of 20,891 patients with suspected acute rnyocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 1990;336:71-75
13. The Gusto Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682
14. Simoons ML, Arnold AER: Tailored thrombolytic therapy: A perspective. Circulation 1993;88:2256-2564
15. Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM, Ross AM, Investigators for GUSTO-I: Link between the angiographie substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Circulation 1995;91:1923-1928
16. Kennedy JW, Gensini G, Timmis GC, Maynard CM: Acute myocardial infarction treated with intracoronary streptokinase: A report of the Society for Cardiac Angiography. Am J Cardiol 1985;55:871-877
17. Becker RC: Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: A theoretical framework for assessing the limitations of thrombolysis in patients with cardiogencic shock. Am Heart J 1993;125:919-929
18. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360
19. Col N, Gurwitz JH, Alpert JS, Goldberg RJ: Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. Am J Cardiol 1994;73:149-157
20. Fibrinolytic Therapy Trialists' (FIT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322
21. AIMS Trial Study Group: Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo controlled clinical trial. Lancet 1988;1:545-549
22. Wilcox RG, van der Lippe G, Olssen CG. Jensen G, Skene AM. Hampton JR, for the ASSET Trial Group: Trial of tisssue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis. ASSET. Lancet 1988;1:525-530
23. Meinertz T, Kasper W, Schumacher M, Just H: The German multicenter trial of anisoylated plasminogen strepokinase activator complex versus heparin for acute myocardial infarction. Am J Cardiol 1988;62:347-351
24. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, Krakauer J, Rubenfire M, Fleming P, Noon G, Oldham N, Killip T, Kantrowitz A: Intra-aortic balloon counterpulsation in cardiogenic shock: Report of a cooperative clinical trial. N Engl J Med 1973; 288:979-984
25. De Wood MA, Notske RN, Hensley GR, Shields JP, O'Grady WP, Spores J, Goldman M, Ganji JH: Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 1980;61:1105-1112
26. Waksman R, Weiss AT, Gotsman MS, Hasin Y: Intra-aortic balloon counterpulsation improves survival in cardiogenic shock. Eur Heart J 1993;14:71-74
27. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H: Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. SHOCK registry investigators. Circulation 1995;91:873-881
28. Domanski MJ, Topol EJ: Cardiogenic shock: Current understandings and future research directions. Am J Cardiol 1994;74:724-726
29. Lee L, Bates ER, Pitt B, Walton J, Laufer N, O'Neill WW: Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988;78:1345-1351
30. Shawl F, Domanski MJ, Hernandez TJ, Punja S: Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction. Am J Cardiol 1989;64:967-970
31. Lee L, Erbel R, Brown TM, Laufer N, Meyer J, O'Neill WW: Multicenter registry of angioplasty therapy of cardiogenic shock: Initial and long term survival. J Am Coll Cardiol 1991;599-603
32. Hibbard MD, Holmes DR. Bailey KR, Reeder GS, Bresnahan JF, Gersh BJ: Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992;19:639-646
33. Gacioch GM, Ellis SG, Lee L, Bates ER, Kirsh M, Walton J, Topol EJ: Cardiogenic shock complicating acute myocardial infarction: The use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol 1992; 19:647-653
34. Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S: Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;19:907-914
35. Bengston JR, Kaplan AJ, Pieper KS, Wildermann NM, Mark DB, Pryor DB. Phillips HR, Califf RM: Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992;20:1482-1489
36. Himbert D, Juliard JM, Steg G, Karillon GJ, Aumont MC, Gourgon R: Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 1994;74:492-494
37. Eltchaninoff H, Simpfendorfer C, Franco I, Raymond R, Casale PN, Whitlow P: Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: A retrospective study comparing coronary angioplasty with medical treatment. Am Heart J 1995;130:459-464
38. Dell' Italia LJ, Starling MR, Blumhardt R, Lasher JC O'Rourke RA: Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation 1985;72:1327-1335
39. Bier JD, Cohen JS, Sleeper L, Levine GN, Davidoff R, Talley JD, Bates E, LeJemtel T, Hochman J, Jacobs AK, for the SHOCK Investigators: Characteristics and outcome of patients with cardiogenic shock due to right ventricular dysfunction: A report from the SHOCK trial registry (abstr). J Am Coll Cardiol 1997;29(suppl A):460A
40. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S, for the SPRINT Study Group: Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome. Am J Med 1993;94:265-273
41. Gibson RS. Bishop HL, Stamm RB, Crampton RC, Beller GA, Martin RP: Value of early two dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol 1982; 49:1110-1119
42. Quigley RL, Milano CA, Smith LR. White WD, Rankin JS, Glower DD: Prognosis and management of anterolateral myocardial infarction in patients with severe left main disease and cardiogenic shock. Circulation 1993;88:65-70
43. Collins R, Peto R, Baigent BM, Sleight P: Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997;336:847-860
44. Grines CL, Browne KR Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Strzelecki M, Puchrowicz-Ochocki S, O'Neill WW, for the PAMI Study Group: A comparison of immediate angioplasty with throm bolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679
45. Stone GW, Grines CL. Browne KP, Marco J, Rothbaum D, O' Keefe J, Hartzler GO, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra R, Puchrowicz-Ochocki S, O'Neill WW: Implications of recurrent ischemia after reperfusion therapy in acute myocaniial infarction: A comparison of thromboiytic therapy and primary angioplasty. J Am Coll Cardiol 1995;26:66-72
46. Zijlstra F, Beukema WP, van't Hoff AWJ, Liem A, Reiffers S, Hoorntje JCA, Suryapranata H, de Boer M: Randomized comparison of primary coronary angioplasty with thromboiytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997;29:908-912
47. Overlie PA, Shawl FA, George BS, Ohman EM, Mooney MR, Freedman RJ, Teirstein PS, Smith SC, Stertzer S, Vogel RA: Cardiogenic shock: Survival rates from the national registry for emergency cardiopulmonary bypass investigators (abstr). J Am Coll Cardiol 1997;29:398A
48. Smalling RW, Sweeney M, Lachterman B, Hess MJ, Morris R, Anderson HV, Heiberg J, Li G, Willerson JT, Frazier H, Wampler RK: Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction: Evidence for recovery from near fatal myocardial stunning. J Am Coll Cardiol 1994;23:637-644